NYSE:DGXHealthcare
Quest Diagnostics (DGX) Margin And EPS Rebound Reinforce Bullish Narratives In Q1 2026
Quest Diagnostics (DGX) opened Q1 2026 with total revenue of US$2.9 billion and basic EPS of US$2.29, setting the tone for how the new year is starting to shape up for the testing giant. Over recent quarters the company has seen revenue move from US$2.6 billion in Q1 2025 to US$2.9 billion in Q1 2026, while basic EPS shifted from US$1.97 to US$2.29. This gives investors a clear view of how the top and bottom lines are tracking through the most recent reporting stretch. With a trailing twelve...